APO RESEARCH · REPORT
Biobanking
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Product & engineering
Understand the product.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Selected research
Industry Growth & Trends
Global Biobanking Industry Growth and Trends Forecast to 2032
Market perspective
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
According to APO Research, the global Biobanking market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Biobanking market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biobanking market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biobanking market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biobanking.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biobanking market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biobanking Market by Company
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Biobanking Segment by Type
Equipment
Consumable
Biobanking Segment by Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Biobanking Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biobanking companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment
- Consumable
Applications
- Virtual Biobanks
- Tissue Biobanks
- Population Biobanks
Companies covered
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Chart Industries
- Brooks Life Science
- Tecan Group
- QIAGEN
- BD
- Lifeline Scientific
- Hamilton
- So-Low
- TTP Labtech Ltd
- Biolife Solutions
- DNA Genotek
- Custom Biogenic Systems
- LVL Technologies
- BioRep
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biobanking Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biobanking Market Size by Region (2021-2032)
- 1.4.1 Global Biobanking Market Size by Region (2021-2026)
- 1.4.2 Global Biobanking Market Size by Region (2027-2032)
- 1.5 Key Regions Biobanking Market Size (2021-2032)
- 1.5.1 North America Biobanking Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biobanking Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biobanking Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biobanking Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biobanking Market Size Growth Rate (2021-2032)
2 Biobanking Market by Type
- 2.1 Type Introduction
- 2.1.1 Equipment
- 2.1.2 Consumable
- 2.2 Global Biobanking Market Size by Type
- 2.2.1 Global Biobanking Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biobanking Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biobanking Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biobanking Market Size by Regions
- 2.3.1 North America Biobanking Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biobanking Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biobanking Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biobanking Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biobanking Market Size Breakdown by Type (2021-2026)
3 Biobanking Market by Application
- 3.1 Type Introduction
- 3.1.1 Virtual Biobanks
- 3.1.2 Tissue Biobanks
- 3.1.3 Population Biobanks
- 3.2 Global Biobanking Market Size by Application
- 3.2.1 Global Biobanking Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biobanking Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biobanking Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biobanking Market Size by Regions
- 3.3.1 North America Biobanking Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biobanking Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biobanking Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biobanking Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biobanking Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biobanking Industry Trends
- 4.2 Biobanking Industry Drivers
- 4.3 Biobanking Industry Opportunities and Challenges
- 4.4 Biobanking Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biobanking Revenue (2021-2026)
- 5.2 Global Biobanking Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biobanking Key Company Headquarters & Area Served
- 5.4 Global Biobanking Company, Product Type & Application
- 5.5 Global Biobanking Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biobanking Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biobanking Players Market Share by Revenue in 2025
- 5.6.3 2025 Biobanking Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher
- 6.1.1 Thermo Fisher Company Information
- 6.1.2 Thermo Fisher Business Overview
- 6.1.3 Thermo Fisher Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Biobanking Product Portfolio
- 6.1.5 Thermo Fisher Recent Developments
- 6.2 Beckman Coulter
- 6.2.1 Beckman Coulter Company Information
- 6.2.2 Beckman Coulter Business Overview
- 6.2.3 Beckman Coulter Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Beckman Coulter Biobanking Product Portfolio
- 6.2.5 Beckman Coulter Recent Developments
- 6.3 Panasonic
- 6.3.1 Panasonic Company Information
- 6.3.2 Panasonic Business Overview
- 6.3.3 Panasonic Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Panasonic Biobanking Product Portfolio
- 6.3.5 Panasonic Recent Developments
- 6.4 SOL Group
- 6.4.1 SOL Group Company Information
- 6.4.2 SOL Group Business Overview
- 6.4.3 SOL Group Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 SOL Group Biobanking Product Portfolio
- 6.4.5 SOL Group Recent Developments
- 6.5 Promega
- 6.5.1 Promega Company Information
- 6.5.2 Promega Business Overview
- 6.5.3 Promega Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Promega Biobanking Product Portfolio
- 6.5.5 Promega Recent Developments
- 6.6 Merck
- 6.6.1 Merck Company Information
- 6.6.2 Merck Business Overview
- 6.6.3 Merck Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Merck Biobanking Product Portfolio
- 6.6.5 Merck Recent Developments
- 6.7 Greiner Bio One
- 6.7.1 Greiner Bio One Company Information
- 6.7.2 Greiner Bio One Business Overview
- 6.7.3 Greiner Bio One Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Greiner Bio One Biobanking Product Portfolio
- 6.7.5 Greiner Bio One Recent Developments
- 6.8 Chart Industries
- 6.8.1 Chart Industries Company Information
- 6.8.2 Chart Industries Business Overview
- 6.8.3 Chart Industries Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Chart Industries Biobanking Product Portfolio
- 6.8.5 Chart Industries Recent Developments
- 6.9 Brooks Life Science
- 6.9.1 Brooks Life Science Company Information
- 6.9.2 Brooks Life Science Business Overview
- 6.9.3 Brooks Life Science Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Brooks Life Science Biobanking Product Portfolio
- 6.9.5 Brooks Life Science Recent Developments
- 6.10 Tecan Group
- 6.10.1 Tecan Group Company Information
- 6.10.2 Tecan Group Business Overview
- 6.10.3 Tecan Group Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Tecan Group Biobanking Product Portfolio
- 6.10.5 Tecan Group Recent Developments
- 6.11 QIAGEN
- 6.11.1 QIAGEN Company Information
- 6.11.2 QIAGEN Business Overview
- 6.11.3 QIAGEN Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 QIAGEN Biobanking Product Portfolio
- 6.11.5 QIAGEN Recent Developments
- 6.12 BD
- 6.12.1 BD Company Information
- 6.12.2 BD Business Overview
- 6.12.3 BD Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 BD Biobanking Product Portfolio
- 6.12.5 BD Recent Developments
- 6.13 Lifeline Scientific
- 6.13.1 Lifeline Scientific Company Information
- 6.13.2 Lifeline Scientific Business Overview
- 6.13.3 Lifeline Scientific Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Lifeline Scientific Biobanking Product Portfolio
- 6.13.5 Lifeline Scientific Recent Developments
- 6.14 Hamilton
- 6.14.1 Hamilton Company Information
- 6.14.2 Hamilton Business Overview
- 6.14.3 Hamilton Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Hamilton Biobanking Product Portfolio
- 6.14.5 Hamilton Recent Developments
- 6.15 So-Low
- 6.15.1 So-Low Company Information
- 6.15.2 So-Low Business Overview
- 6.15.3 So-Low Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 So-Low Biobanking Product Portfolio
- 6.15.5 So-Low Recent Developments
- 6.16 TTP Labtech Ltd
- 6.16.1 TTP Labtech Ltd Company Information
- 6.16.2 TTP Labtech Ltd Business Overview
- 6.16.3 TTP Labtech Ltd Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 TTP Labtech Ltd Biobanking Product Portfolio
- 6.16.5 TTP Labtech Ltd Recent Developments
- 6.17 Biolife Solutions
- 6.17.1 Biolife Solutions Company Information
- 6.17.2 Biolife Solutions Business Overview
- 6.17.3 Biolife Solutions Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Biolife Solutions Biobanking Product Portfolio
- 6.17.5 Biolife Solutions Recent Developments
- 6.18 DNA Genotek
- 6.18.1 DNA Genotek Company Information
- 6.18.2 DNA Genotek Business Overview
- 6.18.3 DNA Genotek Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 DNA Genotek Biobanking Product Portfolio
- 6.18.5 DNA Genotek Recent Developments
- 6.19 Custom Biogenic Systems
- 6.19.1 Custom Biogenic Systems Company Information
- 6.19.2 Custom Biogenic Systems Business Overview
- 6.19.3 Custom Biogenic Systems Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Custom Biogenic Systems Biobanking Product Portfolio
- 6.19.5 Custom Biogenic Systems Recent Developments
- 6.20 LVL Technologies
- 6.20.1 LVL Technologies Company Information
- 6.20.2 LVL Technologies Business Overview
- 6.20.3 LVL Technologies Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 LVL Technologies Biobanking Product Portfolio
- 6.20.5 LVL Technologies Recent Developments
- 6.21 BioRep
- 6.21.1 BioRep Company Information
- 6.21.2 BioRep Business Overview
- 6.21.3 BioRep Biobanking Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 BioRep Biobanking Product Portfolio
- 6.21.5 BioRep Recent Developments
7 North America
- 7.1 North America Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biobanking Market Size by Country (2021-2026)
- 7.3 North America Biobanking Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biobanking Market Size by Country (2021-2026)
- 8.3 Europe Biobanking Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biobanking Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biobanking Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biobanking Market Size by Country (2021-2026)
- 10.3 South America Biobanking Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biobanking Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biobanking Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biobanking Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst